213 related articles for article (PubMed ID: 23775837)
1. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Sanders C; ; Lee WM; Uetrecht J
Hepatology; 2014 Mar; 59(3):1084-93. PubMed ID: 23775837
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid hepatotoxicity: progress in understanding the immunologic component.
James L; Roberts D
Hepatology; 2014 Mar; 59(3):746-8. PubMed ID: 24037911
[No Abstract] [Full Text] [Related]
3. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Lee WM; Uetrecht J
Chem Res Toxicol; 2014 May; 27(5):738-40. PubMed ID: 24786179
[TBL] [Abstract][Full Text] [Related]
4. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
Vuilleumier N; Rossier MF; Chiappe A; Degoumois F; Dayer P; Mermillod B; Nicod L; Desmeules J; Hochstrasser D
Eur J Clin Pharmacol; 2006 Jun; 62(6):423-9. PubMed ID: 16770646
[TBL] [Abstract][Full Text] [Related]
6. N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.
Santos NP; Callegari-Jacques SM; Ribeiro Dos Santos AK; Silva CA; Vallinoto AC; Fernandes DC; de Carvalho DC; Santos SE; Hutz MH
Int J Tuberc Lung Dis; 2013 Apr; 17(4):499-504. PubMed ID: 23394127
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
9. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
10. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
Yue J; Peng RX; Yang J; Kong R; Liu J
Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
[TBL] [Abstract][Full Text] [Related]
11. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
Desta Z; Soukhova NV; Flockhart DA
Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of isoniazid-induced hepatotoxicity: then and now.
Metushi I; Uetrecht J; Phillips E
Br J Clin Pharmacol; 2016 Jun; 81(6):1030-6. PubMed ID: 26773235
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid-induced liver injury and immune response in mice.
Metushi IG; Uetrecht J
J Immunotoxicol; 2014 Oct; 11(4):383-92. PubMed ID: 24303880
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
Boelsterli UA; Lee KK
J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson E; Kenna JG
Mol Pharmacol; 1996 Sep; 50(3):573-82. PubMed ID: 8794896
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP3A in isoniazid metabolism in vivo.
Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
[TBL] [Abstract][Full Text] [Related]
18. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein protects against isoniazid-induced liver injury through the inhibition of CYP2E1-dependent oxidative and nitrosative impairment in mice.
Lian Y; Zhao J; Wang YM; Zhao J; Peng SQ
Food Chem Toxicol; 2017 Apr; 102():32-38. PubMed ID: 28126494
[TBL] [Abstract][Full Text] [Related]
20. CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients.
Perwitasari DA; Irham LM; Darmawan E; Mulyani UA; Atthobari J
Indian J Tuberc; 2016 Jul; 63(3):139-143. PubMed ID: 27865233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
